Are you grappling with challenges in deciphering real-time protein production, identifying proteins actively engaged in cellular processes, or understanding how stimuli like drugs or stress impact translation? Our specialized iTRAQ (Isobaric Tags for Relative and Absolute Quantitation) ribosomal proteomics service helps you accurately quantify newly synthesized proteins and map the actively translating ribosome landscape, providing critical insights into cellular dynamics and responses. Our expert team provides end-to-end support, from experimental design consultation to in-depth bioinformatic analysis, ensuring you receive actionable data tailored to your research questions.
Ribosomal proteomics, or translatomics, focuses on identifying and quantifying proteins that are actively being synthesized by ribosomes at a specific point in time. This provides a direct measure of gene expression at the translational level. iTRAQ is a powerful chemical labeling technique used in quantitative mass spectrometry. By applying iTRAQ to isolated ribosomal fractions, researchers can accurately compare the levels of newly synthesized proteins across multiple samples (e.g., different conditions, and time points), offering crucial insights into translational regulation, cellular responses, and disease mechanisms.
Fig.1 Identification and analysis of proteins that differentially accumulated between NS and PS.1
Our iTRAQ ribosomal proteomics quantification service is a meticulously designed process to ensure the highest quality data and insights.
This includes a detailed summary of the experimental procedure, quality control metrics, a list of all identified and quantified ribosomal proteins with their relative abundance ratios across samples, and statistical analysis highlighting significantly regulated proteins.
Including Gene Ontology (GO) enrichment analysis, pathway mapping, and visualization plots to help interpret the biological significance of the findings.
Full access to the raw mass spectrometry data files and processed data tables for your records and further independent analysis.
Our team has extensive experience specifically in ribosomal profiling and quantitative proteomics, ensuring your samples are handled optimally and data is interpreted accurately.
We utilize state-of-the-art mass spectrometry platforms coupled with optimized iTRAQ labeling protocols to maximize sensitivity, coverage, and quantitative accuracy for ribosome-associated proteins.
We go beyond simple protein lists, providing in-depth bioinformatic analysis, including pathway and functional enrichment, to help you extract maximum biological meaning from your data.
We work closely with you from experimental design to data interpretation, ensuring the project is tailored to your specific research aims and that you fully understand the results.
Stringent QC measures are implemented at every step, from sample receipt to final report generation, guaranteeing reliable and reproducible outcomes.
This field focuses on identifying dysregulated protein synthesis pathways in cancers, neurodegenerative disorders, cardiovascular diseases, and metabolic syndromes. By mapping aberrant translational programs, researchers aim to uncover how misregulated protein translation drives disease initiation, progression, and drug resistance.
Drug discovery leverages translational profiling to identify novel therapeutic targets and validate mechanisms of action. By pinpointing ribosomal proteins or translation factors uniquely altered in disease states, researchers can design inhibitors to disrupt oncogenic translation. Translatome analysis further reveals how drug candidates directly modulate protein synthesis, enabling efficacy and safety assessments.
Biomarker discovery exploits actively synthesized proteins as indicators of physiological states or disease progression. Using techniques like ribosome profiling or mass spectrometry, researchers identify proteins whose translation rates correlate with treatment response or early disease detection.
Cells adapt to environmental stressors by reprogramming protein synthesis. Studies reveal that stress-induced phosphorylation of eIF2α suppresses global translation while prioritizing stress-response proteins. Understanding these translational control mechanisms, such as the integrated stress response (ISR), aids in developing therapies for stress-related diseases.
Understanding translational responses in crops under stress enables the engineering of stress-tolerant varieties. For example, modulating ribosome biogenesis or translation initiation factors in plants enhances drought resistance without yield penalties. Translational profiling also identifies proteins whose synthesis improves nutritional value or post-harvest shelf life. These strategies address global food security challenges by optimizing crop resilience and quality.
A: While total proteomics measures the overall abundance of proteins, iTRAQ ribosomal proteomics specifically quantifies proteins that are actively being synthesized by ribosomes. This provides a more dynamic and direct view of gene expression regulation at the translational level, which can be crucial for understanding rapid cellular responses or the immediate impact of treatments.
A: This service is ideal for investigating how various stimuli affect protein synthesis, identifying proteins whose translation is dysregulated, discovering biomarkers for active cellular processes, or understanding the mechanisms of translational control. If you're looking to see how your system is actively responding by making new proteins, this is a powerful tool.
A: Yes, preserving the integrity of ribosomes and the associated mRNA-protein complexes is critical. This usually involves rapid sample harvesting, snap-freezing, and often the use of translation inhibitors like cycloheximide during collection if you want to capture a specific snapshot of active translation.
Ready to explore how our iTRAQ ribosomal proteomics quantification service can elevate your research? Contact our team for more information.
Reference
(USA)
(UK)
(Germany)